Right to Terminate or Suspend Study. SPONSOR or the Institution may terminate or suspend any Study at the Institution’s facilities immediately upon written notice to the other for safety concerns, withdrawal of approval to continue the Study by the IRB or FDA, or as otherwise required by Applicable Laws. Further, SPONSOR may immediately terminate or suspend any Study if such Study is terminated or suspended at all other Study sites. SPONSOR or Institution may terminate the Institution’s participation in a Study, in its sole discretion, without cause, on thirty (30) days prior written notice to the other party. SPONSOR or the Institution may terminate a SOW in the event of material breach by the other of this Agreement or the applicable SOW, provided that the other is given written notice of the nature of the default and an opportunity to cure such default within a period of thirty (30) business days after the giving of notice. Termination of a SOW shall constitute termination of such SOW only, and shall not affect this Agreement or any other SOW.
Appears in 6 contracts
Samples: Master Clinical Study Agreement, Master Clinical Study Agreement, Master Clinical Study Agreement